ClearPoint Neuro, Inc. (CLPT)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenue | 9,215 | 8,485 | 8,122 | 7,858 |
| Cost of revenue | 3,659 | 3,353 | 3,275 | 2,870 |
| Gross profit | 5,556 | 5,132 | 4,847 | 4,988 |
| Research and development costs | 3,829 | 3,379 | 3,315 | 3,120 |
| Sales and marketing expenses | 4,019 | 3,834 | 3,549 | 3,834 |
| General and administrative expenses | 3,388 | 4,082 | 3,155 | 2,773 |
| Operating loss | -5,680 | -6,163 | -5,172 | -4,739 |
| Interest income (expense), net | -80 | 151 | 209 | 326 |
| Other income (expense), net | -52 | 4 | -11 | 5 |
| Net loss before income taxes | -5,812 | -6,008 | - | - |
| Income tax expense | 25 | 18 | - | - |
| Net loss | -5,837 | -6,026 | -4,974 | -4,408 |
| Earnings per share, basic | -0.21 | -0.22 | -0.18 | -0.16 |
| Earnings per share, diluted | -0.21 | -0.22 | -0.18 | -0.16 |
| Weighted average number of shares outstanding, basic | 28,258,305 | 27,718,918 | 27,591,623 | 27,468,378 |
| Weighted average number of shares outstanding, diluted | 28,258,305 | 27,718,918 | 27,591,623 | 27,468,378 |